ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT

Practical Radiation Oncology - Tập 12 - Trang 335-347 - 2022
Nicholas Damico1, Joshua Meyer2, Prajnan Das3, James Murphy4, Eric Miller5, Bridget Koontz6, William Hall7, Mary McBride1, Gisele Pereira1, Paul Catalano8, A. Bapsi Chakravarthy9, Peter J. O'Dwyer10, Jennifer Dorth1
1Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio
2Fox Chase Cancer Center, Philadelphia, Pennsylvania
3MD Anderson Cancer Center, Houston, Texas
4UC San Diego Moores Cancer Center, San Diego, California
5The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
6Duke University Medical Center, Durham, North Carolina
7Medical College of Wisconsin, Milwaukee, Wisconsin
8Dana Farber Cancer Institute, Boston, Massachusetts and ECOG-ACRIN Biostatistics Center
9Vanderbilt University Ingram Cancer Center, Nashville, Tennessee
10University of Pennsylvania, Philadelphia, Pennsylvania

Tài liệu tham khảo

Myerson, 2009, Elective clinical target volumes for conformal therapy in anorectal cancer: A Radiation Therapy Oncology Group consensus panel contouring atlas, Int J Radiat Oncol Biol Phys, 74, 824, 10.1016/j.ijrobp.2008.08.070

Ng, 2012, Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer, Int J Radiat Oncol Biol Phys, 83, 1455, 10.1016/j.ijrobp.2011.12.058

Ortholan, 2005, Anal canal carcinoma: Early-stage tumors < or =10 mm (T1 or Tis): Therapeutic options and original pattern of local failure after radiotherapy, Int J Radiat Oncol Biol Phys, 62, 479, 10.1016/j.ijrobp.2004.09.060

Gunderson, 2013, Anal carcinoma: Impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial, Int J Radiat Oncol Biol Phys, 87, 638, 10.1016/j.ijrobp.2013.07.035

Shakir, 2020, Patterns and predictors of relapse following radical chemoradiation therapy delivered using intensity modulated radiation therapy with a simultaneous integrated boost in anal squamous cell carcinoma, Int J Radiat Oncol Biol Phys, 106, 329, 10.1016/j.ijrobp.2019.10.016

Han, 2014, Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer, Int J Radiat Oncol Biol Phys, 90, 587, 10.1016/j.ijrobp.2014.06.061

XXX

Kachnic, 2013, RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal, Int J Radiat Oncol Biol Phys, 86, 27, 10.1016/j.ijrobp.2012.09.023

Muirhead, 2014, Anal cancer: Developing an intensity- modulated radiotherapy solution for ACT2 fractionation, Clin Oncol (R Coll Radiol), 26, 720, 10.1016/j.clon.2014.08.001

Lengele, 2009, Anatomical bases for the radiological delineation of lymph node areas. Part III: Pelvis and lower limbs, Radiother Oncol, 92, 22, 10.1016/j.radonc.2008.11.007

Taylor, 2005, Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 63, 1604, 10.1016/j.ijrobp.2005.05.062

Dinniwell, 2009, Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging, Int J Radiat Oncol Biol Phys, 74, 844, 10.1016/j.ijrobp.2008.09.026

Vilarino-Varela, 2008, A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging, Radiother Oncol, 89, 192, 10.1016/j.radonc.2008.07.023

Shih, 2005, Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy, Int J Radiat Oncol Biol Phys, 63, 1262, 10.1016/j.ijrobp.2005.07.952

Grimes, 2020, Reduced clinical and planning treatment volumes for anal squamous cell carcinoma yield acceptable outcomes, Int J Radiat Oncol Biol Phys, 108, e593, 10.1016/j.ijrobp.2020.07.1813

Nilsson, 2020, Patterns of recurrence in anal cancer: A detailed analysis, Radiat Oncol, 15, 125, 10.1186/s13014-020-01567-7

Briere, 2012, Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients, Radiother Oncol, 104, 161, 10.1016/j.radonc.2012.05.011

Kim, 2005, Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients, Int J Radiat Oncol Biol Phys, 62, 769, 10.1016/j.ijrobp.2004.11.015

Kim, 2017, The effect of prone and supine treatment positions for the pre-operative treatment of rectal cancer on organ-at-risk sparing and setup reproducibility using volumetric modulated arc therapy, Radiat Oncol, 12, 180, 10.1186/s13014-017-0918-5

Heijkoop, 2016, Optimal patient positioning (prone versus supine) for VMAT in gynecologic cancer: A dosimetric study on the effect of different margins, Int J Radiat Oncol Biol Phys, 96, 432, 10.1016/j.ijrobp.2016.05.025

Osborne, 2017

Gaffney, 2016, Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma, Int J Radiat Oncol Biol Phys, 95, 1191, 10.1016/j.ijrobp.2016.02.043

de Meric de Bellefon, 2020, Long-term follow-up experience in anal canal cancer treated with intensity-modulated radiation therapy: Clinical outcomes, patterns of relapse and predictors of failure, Radiother Oncol, 144, 141, 10.1016/j.radonc.2019.11.016

Kachnic, 2022, Long-term outcomes of NRG Oncology/RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in anal canal cancer, Int J Radiat Oncol Biol Phys, 112, 146, 10.1016/j.ijrobp.2021.08.008

Rahma, 2021, Use of total neoadjuvant therapy for locally advanced rectal cancer: Initial results from the pembrolizumab arm of a phase 2 randomized clinical trial, JAMA Oncol, 7, 1225, 10.1001/jamaoncol.2021.1683

Matthews, 2011, T1-2 anal carcinoma requires elective inguinal radiation treatment—the results of Trans Tasman Radiation Oncology Group study TROG 99.02, Radiother Oncol, 98, 93, 10.1016/j.radonc.2010.10.005

Ortholan, 2012, Anal canal cancer: Management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study), Int J Radiat Oncol Biol Phys, 82, 1988, 10.1016/j.ijrobp.2011.02.010

Das, 2007, Predictors and patterns of recurrence after definitive chemoradiation for anal cancer, Int J Radiat Oncol Biol Phys, 68, 794, 10.1016/j.ijrobp.2006.12.052

Valentini, 2016, International consensus guidelines on clinical target volume delineation in rectal cancer, Radiother Oncol, 120, 195, 10.1016/j.radonc.2016.07.017

Nuikolouzakis, 2019, Detailed and applied anatomy for improved rectal cancer treatment, Ann Gastroenterol, 32, 431

Yun, 2008, Intra-operative measurement of surgical lengths of the rectum and the peritoneal reflection in Korean, J Korean Med Sci, 23, 999, 10.3346/jkms.2008.23.6.999

Durrant, 2016, Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT), Radiother Oncol, 121, 92, 10.1016/j.radonc.2016.08.011

Nijkamp, 2009, Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients, Radiother Oncol, 92, 202, 10.1016/j.radonc.2009.04.022

Nijkamp, 2009, Target volume shape variation during irradiation of rectal cancer patients in supine position: Comparison with prone position, Radiother Oncol, 93, 285, 10.1016/j.radonc.2009.08.007

Glynne-Jones, 2017, Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): A post-hoc analysis of randomised controlled phase 3 trial, Lancet Oncol, 18, 347, 10.1016/S1470-2045(17)30071-2

Kachnic, 2012, Dose-painted intensity-modulated radiation therapy for anal cancer: A multi-institutional report of acute toxicity and response to therapy, Int J Radiat Oncol Biol Phys, 82, 153, 10.1016/j.ijrobp.2010.09.030

Gunderson, 2012, Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin, J Clin Oncol, 30, 4344, 10.1200/JCO.2012.43.8085

Sebag-Montefiore, 2012, The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial, J Clin Oncol, 30

Julie, 2016, Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma, Acta Oncol, 55, 208, 10.3109/0284186X.2015.1043396

Lee, 2017, Hematologic nadirs during chemoradiation for anal cancer: Temporal characterization and dosimetric predictors, Int J Radiat Oncol Biol Phys, 97, 306, 10.1016/j.ijrobp.2016.10.010

Rose, 2011, Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy, Int J Radiat Oncol Biol Phys, 79, 800, 10.1016/j.ijrobp.2009.11.010

Bazan, 2012, Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal, Int J Radiat Oncol Biol Phys, 84, 700, 10.1016/j.ijrobp.2011.12.072

Mell, 2008, Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy, Int J Radiat Oncol Biol Phys, 70, 1431, 10.1016/j.ijrobp.2007.08.074

Rose, 2017, Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation, Pract Radiat Oncol, 7, e291, 10.1016/j.prro.2017.03.008

Son, 2015, Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer, Int J Radiat Oncol Biol Phys, 92, 548, 10.1016/j.ijrobp.2015.02.029

Price, 2014, Planning target volume-to-skin proximity for head-and-neck intensity modulated radiation therapy treatment planning, Pract Radiat Oncol, 4, e21, 10.1016/j.prro.2013.04.002

Kinhikar, 2009, Skin dose measurements using MOSFET and TLD for head and neck patients treated with tomotherapy, Appl Radiat Isot, 67, 1683, 10.1016/j.apradiso.2009.03.008

Rouard, 2019, Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence, Radiother Oncol, 131, 93, 10.1016/j.radonc.2018.10.021

Dorth, 2020, EA2182 (DECREASE): Radiation Plan Central Review, Paper presented at: ECOG-ACRIN Cancer Research Group, Fall 2020 Virtual Group Meeting, Radiation Oncology Committee Meeting

Thông tin
Thông tin xuất bản

Practical Radiation Oncology

Tập 12

335-347

Thông tin tác giả